Sign in

CIK 0000875320

  • Large accelerated filer

VERTEX PHARMACEUTICALS INC / MA

Sign in to watch
Ticker
VRTX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
MA
Entity type
Operating
EIN
043039129
Phone
+1 617-341-6393
Business address
50 NORTHERN AVENUE, BOSTON, MA, 02210
  1. 4 Planned sale EVP and CMO sold 1,745 shares at $450.00 ($785,250)
  2. 4 Planned sale EVP and Chief Legal Officer sold 828 shares at $439.91 ($364,245)
  3. 4 Planned sale EVP and CMO sold 1,974 shares at $450.00 ($888,300)
  4. 4 Planned sale EVP, Chief Scientific Officer sold 33 shares at $453.45 ($14,964)
  5. 4 Planned sale EVP and CMO sold 1,354 shares at $453.45 ($613,971)
  6. 4 Planned sale EVP and CMO sold 6,988 shares at $450.00 ($3,144,600)
  7. 4 Returned to the company Director returned 796 shares (to the company)
  8. 4 Grant or award Director acquired 472 shares (grant or award)
  9. 4 Grant or award Director acquired 472 shares (grant or award)
  10. 4 Derivatives Options or other derivatives
  11. 4 Grant or award Director acquired 943 shares (grant or award)
  12. 4 Planned sale EVP and Chief Legal Officer sold 1,104 shares at $425.02 ($469,222)
  13. 4 Derivatives Options or other derivatives
  14. 4 Grant or award Director acquired 472 shares (grant or award)
  15. 4 Derivatives Options or other derivatives
  16. 4 Planned sale Director sold 318 shares at $423.73 ($134,746)
  17. 4 Derivatives Options or other derivatives
  18. 4 Derivatives Options or other derivatives
  19. 4 Derivatives Options or other derivatives
  20. 4 Planned sale EVP and Chief Legal Officer sold 978 shares at $449.17 ($439,288)

Page 2 of 129 · 2,566 filings